The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern

Diabetes Obes Metab. 2012 Jan;14(1):1-4. doi: 10.1111/j.1463-1326.2011.01469.x. Epub 2011 Nov 21.

Abstract

There is no doubt about the value of exogenous insulin for people with type 1 diabetes. The purpose of this commentary is to discuss emerging evidence that this may not be the case for the majority of people with type 2 diabetes.

Publication types

  • Review

MeSH terms

  • Diabetes Mellitus, Type 1 / drug therapy
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetic Angiopathies / blood
  • Diabetic Angiopathies / chemically induced*
  • Humans
  • Hypoglycemia / blood
  • Hypoglycemia / chemically induced*
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / blood
  • Insulin / administration & dosage
  • Insulin / adverse effects*
  • Insulin / blood
  • Risk Assessment

Substances

  • Hypoglycemic Agents
  • Insulin